Roche and Take­da try on Em­u­late’s 'or­gan chip' tech for R&D

Two phar­ma gi­ants — Roche and Take­da — are buy­ing in­to a drug test­ing tech­nol­o­gy that wants to be the next gen­er­a­tion’s “lab rat,” ink­ing part­ner­ships with the tech’s mak­er to in­tro­duce the sys­tems to their R&D labs.

The tech, made by Wyss In­sti­tute spin­off Em­u­late, in­cludes small chips de­signed to hold liv­ing cells in cham­bers. These chips are en­gi­neered to recre­ate the en­vi­ron­ment cells might ex­pe­ri­ence in the hu­man body, in­tro­duc­ing me­chan­i­cal forces that mim­ic breath­ing, for ex­am­ple.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER